IMIPRAMINE FOR USE AS AN INHIBITOR OF FASCIN1 OVEREXPRESSION

摘要

The present invention refers to imipramine for use as an inhibitor of fascin1 overexpression. Preferably said overexpression of fascin1 is associated with cancer, and more preferably with colorectal cancer. The invention also relates to a method for the treatment of cancer mediated by fascin1 involving administering an effective amount of imipramine to a subject in need, and more preferably for colorectal cancer.